The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation.
about
Off-target effects of BCR-ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia.The impact of dasatinib on pregnancy outcomes.Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia.A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiforme.Micellar formulations of Crizotinib and Dasatinib in the management of glioblastoma multiforme.The complexity of growth failure in children receiving tyrosine kinase inhibitor therapy for chronic myelogenous leukemia.Engineering DN hydrogels from regenerated silk fibroin and poly(N-vinylcaprolactam)
P2860
Q33401360-F6563A34-6184-430B-B602-C1554E361B75Q37423501-B2E82365-F14F-4FEC-B020-99C6616B833CQ37989418-71F11833-E737-4A53-B21B-AAE1F02D4310Q38262123-5DD54610-2039-46A4-B9D5-BF7CA8C10B83Q47292301-3EE7B92F-B2FE-40DA-8EDC-5439BE544E59Q48146200-4F7F55A6-264A-439D-85F8-C70F30EDB1F3Q57369342-59F1FD28-4824-4432-A4D3-A606761452AB
P2860
The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The tyrosine kinase inhibitor ...... te activity and proliferation.
@ast
The tyrosine kinase inhibitor ...... te activity and proliferation.
@en
type
label
The tyrosine kinase inhibitor ...... te activity and proliferation.
@ast
The tyrosine kinase inhibitor ...... te activity and proliferation.
@en
prefLabel
The tyrosine kinase inhibitor ...... te activity and proliferation.
@ast
The tyrosine kinase inhibitor ...... te activity and proliferation.
@en
P2093
P2860
P356
P1433
P1476
The tyrosine kinase inhibitor ...... te activity and proliferation.
@en
P2093
A C W Zannettino
P2860
P2888
P356
10.1038/BCJ.2011.1
P577
2011-02-04T00:00:00Z